← Back
▼ SELL

$ Value

$1.5M

Shares

6,173

Price

$237

Filed

Nov 26

Insider

Name

BOTHA ROELOF

Title

CIK

0001222287

Roles

Director

Transaction Details

Transaction Date

2025-11-24

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,188,873

Footnotes

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.70 to $229.63. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | Includes 4,411 shares transferred to an estate planning vehicle in a transaction exempt from Section 16 pursuant to Rule 16a-13. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.05. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.04 to $231.83. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.09 to $233.08. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.09 to $234.08. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.09 to $235.08. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.09 to $236.08. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.09 to $237.08. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.09 to $238.08. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.09 to $239.07. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth above.

Filing Info

Accession No.

0001607841-25-000013

Form Type

4

Issuer CIK

0001604821

BOTHA ROELOF's History

Date Ticker Type Value
2026-04-01 XYZ A $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE C $0
2026-01-30 LIFE D $0
2026-01-30 LIFE D $0
2026-01-30 LIFE D $0

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10